Glucosamine and chondroitin in osteoarthritis treatment

Osteoarthritis remains a challenge in most parts of the world most particularly considering that one of the influencing factors, aging, cannot be avoided. Glucosamine and chondroitin have been used against the disorder for many years and have a huge market base in Europe and the United States where they are generally marketed as sulfates. Research shows that they are effective options against the disease at various levels, in vivo and clinical trials, but a better clinical position is required from more research as well as by using analogs of their chemical structures.